Inhalable metal organic framework (MOF) aerosols have been developed via spray drying as a therapy for multi-drug resistant (MDR) tuberculosis (TB). The CuPOA (pyrazinoate acid) MOFs can be tailored to exhibit a respirable mass median aerodynamic diameter (MMAD) of 2.6 μm. This method is repeated to manufacture GdCu(POA) MOFs for inhalable theragnostics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d0cc05471b | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!